Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Novel anaplastic lymphoma kinase inhibitors claimed by IRM

April 14, 2009

Novel piperidine derivatives claimed by Astellas Pharma

April 14, 2009

Cetuximab with chemotherapy as first-line treatment for metastatic colorectal cancer

April 9, 2009

Cancer Therapy & Research Center and OncoVista collaborate on OVI-117

April 9, 2009

Array BioPharma patent claims new tyrosine kinase inhibitors for cancer treatment

April 9, 2009

Novel series of hypoxia-activated compounds identified by Threshold Pharmaceuticals

April 9, 2009

Screening study shows reduced prostate cancer risk with finasteride across PSA levels

April 9, 2009

Genta completes patient enrollment in global phase III Genasense trial

April 8, 2009

Novel JAK1/JAK2 inhibitor developed by Cytopia for the treatment of myeloproliferative disorders

April 8, 2009

Positive phase II findings for Reolysin with radiation in advanced cancers

April 8, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...